What Next TBD: The Never-Ending Cancer Drug Shortage

A shortage of basic chemotherapy drugs to treat cancer is jeopardizing the care of hundreds of thousands of patients. The drugs aren’t expensive, or patented—so where are they? 

Guest: Ed Yong, science journalist at The Atlantic.
Host: Lizzie O'Leary

If you enjoy this show, please consider signing up for Slate Plus. Slate Plus members get benefits like zero ads on any Slate podcast, bonus episodes of shows like Slow Burn and Dear Prudence—and you’ll be supporting the work we do here on What Next TBD. Sign up now at slate.com/whatnextplus to help support our work.
Learn more about your ad choices. Visit megaphone.fm/adchoices

A shortage of basic chemotherapy drugs to treat cancer is jeopardizing the care of hundreds of thousands of patients. The drugs aren’t expensive, or patented—so where are they? 

Guest: Ed Yong, science journalist at The Atlantic.

Host: Lizzie O'Leary

If you enjoy this show, please consider signing up for Slate Plus. Slate Plus members get benefits like zero ads on any Slate podcast, bonus episodes of shows like Slow Burn and Dear Prudence—and you’ll be supporting the work we do here on What Next TBD. Sign up now at slate.com/whatnextplus to help support our work.

Learn more about your ad choices. Visit megaphone.fm/adchoices